Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

AH 6809

  Cat. No.:  DC23233   Featured
Chemical Structure
33458-93-4
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
A xanthone derivative that fuctions as an EP and DP receptor antagonist.
Cas No.: 33458-93-4
Chemical Name: AH6809
Synonyms: 9H-Xanthene-2-carboxylicacid, 6-(1-methylethoxy)-9-oxo-;6-(1-methylethoxy)-9-oxo-9H-Xanthene-2-carboxylic acid;9-oxo-6-propan-2-yloxyxanthene-2-carboxylic acid;AH 6809;6-isopropoxy-9-oxo-9h-xanthene-2-carboxylic acid;6-Isopropoxy-9-oxoxanthene-2-carboxylic acid;AH-6809;Tocris-0671;6-ISOPROPOXY-9-XANTHONE-2-CARBOXYLIC ACID;HMS3648F13;PDSP1_001548;PDSP1_001548;HMS3675O12;HMS3675O12;J-019193;J-019193;CAS_33458-93-4;CAS_33458-93-4;SR-01000597664-2;SR-01000597664-2;AH6809;AH6809;9H-Xanthene-2-carboxylic acid, 6-(1-methylethoxy)-9-oxo-;9H-Xanthene-2-carboxylic acid, 6-(1-methylethoxy)-9-oxo-;AQFFXPQJLZFABJ-UHFFFAOYSA-N;AQFFXPQJLZFABJ-UHFFFAOYSA-N;NSC_119461;NSC_119461;HY-10418;HY-10418;NU957VN2AW;NU957VN2AW;A913344;A913344;BRD-K59339270-001-01-8;BRD-K59339270-001-01-8;33458-93-4;33458-93-4;SR-01000597664;SR-01000597664;BS-52004;BS-52004;SCHEMBL1163801;CHEMBL1317823;SCHEMBL1163801;HMS3266H17;CHEMBL1317823;GTPL1896;HMS3266H17;PDSP2_001532;GTPL1896;L000101;PDSP2_001532;SR-01000597664-1;L000101;AKOS024458601;SR-01000597664-1;HMS3411O12;AKOS024458601;9-OXO-6-(PROPAN-2-YLOXY)-9H-XANTHENE-2-CARBOXYLIC ACID;HMS3411O12;CHEBI:95289;9-OXO-6-(PROPAN-2-YLOXY)-9H-XANTHENE-2-CARBOXYLIC ACID;6-Isopropoxy-9-xanthone-2-carboxylic acid;CHEBI:95289;BDBM85184;6-Isopropoxy-9-xanthone-2-carboxylic acid;Q27074359;BDBM85184;NCGC00024721-01;Q27074359;EX-A7711;NCGC00024721-01;6-Isopropoxy-9-xanthone-2-carboxylicacid;EX-A7711;6-(1-Methylethoxy)-9-oxo-9H-xanthene-2-carboxylic acid;6-Isopropoxy-9-xanthone-2-carboxylicacid;DTXSID80187106;6-(1-Methylethoxy)-9-oxo-9H-xanthene-2-carboxylic acid;CS-1549;DTXSID80187106;AH6809, >=98%, crystalline solid or supercooled liquid;E85579;CS-1549;AH6809, >=98%, crystalline solid or supercooled liquid;E85579;BRD-K59339270-001-02-6;DB-359128;DTXCID50109597
SMILES: O=C1C2=C(C=CC(C(O)=O)=C2)OC3=CC(OC(C)C)=CC=C31
Formula: C17H14O5
M.Wt: 298.294
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: A xanthone derivative that fuctions as an EP and DP receptor antagonist; blocks the PGE2-induced accumulation of cAMP in COS cells transfected with the human EP2 receptor; an effective antagonist antiaggregatory actions of PGD2, but not PGI2, with EC50 50 uM in whole human platelet.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868 AZ14133346 AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865 TI17 ​​TI17​​ represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816 Nisoxetine Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641 GENZ-644282 TFA salt Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325 PSMA-617 TFA PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202 Fosaprepitant free acid Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748 O4I4 O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684 ZH8667 ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646 EB-PSMA-617 EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.
X